Priceline’s Sisterhood Foundation relaunches with expanded focus

The Priceline Sisterhood Foundation is embarking on a transformative new chapter. Renamed the Sisterhood Foundation, the organisation has raised over $10 million in the past 13 years and is now broadening its impact with an updated purpose, visual identity, and expanded network of charity partners.

With a renewed focus on addressing the unique health and wellbeing challenges faced by Australian women and girls, the Sisterhood Foundation aims to amplify its support for frontline charities that drive real change. Chair of the Sisterhood Foundation and Wesfarmers Health Managing Director, Emily Amos, celebrated the relaunch as a pivotal step: “The Sisterhood Foundation has a proud history of supporting Australian women and their families. This exciting next chapter will further strengthen the Sisterhood’s impact and empower our new and existing Charity Partners to keep growing and supporting women and girls across the country.”

As part of its evolution, the Foundation has welcomed four new Charity Partners:

Jean Hailes for Women’s Health, focusing on education and awareness around women’s health.
Smiling Mind, promoting mental health and wellness through mindfulness programs.
Her Heart, dedicated to improving heart health for women.
Share the Dignity, addressing period poverty for women and girls experiencing homelessness, domestic violence, and disadvantage.

These organisations join the Sisterhood’s four existing partners:

Motherless Daughters, supporting women and girls grieving the loss of their mothers.
PANDA, addressing perinatal anxiety and depression.
Fitted for Work, empowering women seeking employment to become job-ready.
SisterWorks, helping refugee, migrant, and asylum-seeking women achieve economic independence.

From 2025, the Sisterhood Foundation will become the official charitable cause for all Wesfarmers Health businesses, including SILK Laser Clinics, Clear Skincare, InstantScripts, and SiSU Health Group, alongside Priceline Pharmacy and Australian Pharmaceutical Industries.